Michael S. Leapman

Michael S. Leapman, MD, MHS is an Associate Professor of Urology at Yale School of Medicine with secondary appointment in Chronic Disease Epidemiology. He serves as Clinical Program Leader for the Prostate & Urologic Cancers Program at Yale Cancer Center and maintains a joint appointment at the West Haven VA Medical Center. Dr. Leapman specializes in urologic oncology with focus on prostate, bladder, kidney, and testicular cancers.

Education includes:

• B.A. in Neurobiology & Behavior, Cornell University (2005)
• M.D., University of Maryland School of Medicine (2009)
• Residency in General Surgery & Urology, Mount Sinai Medical Center (2014)
• Fellowship in Urologic Oncology, University of California San Francisco (2016)
• M.H.S., Yale University (2022)

His research program examines:

• Prostate cancer management strategies including active surveillance and robotic surgery
• Health services outcomes in urologic oncology
• Imaging stewardship and guideline-concordant care
• Healthcare disparities in diagnostic access
• Environmental sustainability in urologic practice

He has pioneered work in single-port robotic prostatectomy and MRI-guided biopsy techniques.

Honors and awards:

• John N. Forrest Jr. Prize for Mentorship (2022)
• Best Poster, European School of Oncology (2016)
• Conquer Cancer Foundation Merit Award (2015)
• First Place Essay, AUA Western Section (2015)
• Outstanding Abstract Award, UCSF (2015)

Dr. Leapman participates in clinical trials including the SIMCAP trial for metastatic prostate cancer and serves as mentor through Yale's research training programs. His collaborative work appears in high-impact journals including Journal of the National Cancer Institute, European Urology, and JAMA Oncology.